P. Rüegg

Tegaserod, a 5‐HT₄ receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

S. Müller‐Lissner, I. Fumagalli, Karna Dev Bardhan et al. · Alimentary Pharmacology & Therapeutics · 2001 · 464 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

J. Novick, Philip B. Miner, Richard A. Krause et al. · Alimentary Pharmacology & Therapeutics · 2002 · 291 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A double‐blind, placebo‐controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

Henry Nyhlin, Christen J. Bang, L Elsborg et al. · Scandinavian Journal of Gastroenterology · 2004 · 107 citations

Medicine, Pharmacology, Pharmacotherapy +11

The effect of a new inotropic agent, DPI 201‐106, on systolic time intervals and the electrocardiogram in healthy subjects.

P. Rüegg, E. Nüesch · British Journal of Clinical Pharmacology · 1987 · 18 citations · Full text

Medicine, Cardiology, Pharmacology +16